Cancer
Malignant Kidney Neoplasm
CI-CAN-00003171Explore in graph →
Top-level453 active trials17 approved drugs80 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00003171Explore in graph →
Clinical trials
2,143 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (339)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01243359 | Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies | completed | Phase 1 | 6 | National Cancer Institute (NCI)NIH | 1 | Apr 2, 2014 | clinicaltrials |
| NCT00193154 | OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma | completed | Phase 2 | 63 | SCRI Development Innovations, LLCOTHER | 1 | Apr 1, 2014 | clinicaltrials |
| NCT00356460 | Safety and Efficacy Study of GC1008 to Treat Renal Cell Carcinoma or Malignant Melanoma | completed | Phase 1 | 29 | Genzyme, a Sanofi CompanyINDUSTRY | 1 | Mar 19, 2014 | clinicaltrials |
| NCT00890747 | Sunitinib Malate in Treating HIV-Positive Patients With Cancer Receiving Antiretroviral Therapy | completed | Phase 1 | 42 | National Cancer Institute (NCI)NIH | 1 | Mar 17, 2014 | clinicaltrials |
| NCT01577784 | Pazopanib in Second-line Therapy in Renal Cell Carcinoma | unknown | Phase 2 | 27 | Associació per a la Recerca Oncologica, SpainOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00004135 | Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Melanoma or Metastatic Kidney Cancer | completed | Phase 2 | 19 | University of ChicagoOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT00459979 | Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery | completed | Phase 2 | 30 | Case Comprehensive Cancer CenterOTHER | 1 | Mar 7, 2014 | clinicaltrials |
| NCT02073110 | Optical Biopsy to Improve the Diagnosis of Kidney Cancer | unknown | — | 194 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Feb 27, 2014 | clinicaltrials |
| NCT00900042 | SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer | completed | — | 34 | SWOG Cancer Research NetworkNETWORK | 0 | Feb 25, 2014 | clinicaltrials |
| NCT00348699 | AFP464 in Treating Patients With Metastatic or Refractory Solid Tumors That Cannot Be Removed By Surgery | completed | Phase 1 | 68 | National Cancer Institute (NCI)NIH | 1 | Feb 24, 2014 | clinicaltrials |
| NCT01836406 | Effect of Ketorolac and Remote Ischemic Preconditioning on Renal Ischemia-reperfusion Injury in Patients Undergoing Partial Nephrectomy | completed | N/A | 16 | Yonsei UniversityOTHER | 1 | Feb 19, 2014 | clinicaltrials |
| NCT00891475 | Palliative Radiofrequency Ablation in Metastatic Renal Cell Carcinoma Patients | completed | Phase 1 / Phase 2 | 114 | Kidney Cancer Research BureauOTHER | 1 | Feb 13, 2014 | clinicaltrials |
| NCT00523640 | A Phase II Trial of Gemcitabine, Capecitabine, and Bevacizumab in Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 30 | University of ChicagoOTHER | 1 | Feb 11, 2014 | clinicaltrials |
| NCT00073307 | Study of BAY43-9006 in Patients With Unresectable and/or Metastatic Renal Cell Cancer | completed | Phase 3 | 903 | BayerINDUSTRY | 19 | Feb 6, 2014 | clinicaltrials |
| NCT00980213 | Evaluation of the Cost and Effectiveness Sunitinib Compared to Interferon-Alfa in Finland | completed | — | 80 | Pirkko-Liisa Kellokumpu-LehtinenOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT02056587 | Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment | completed | Phase 4 | 37 | Kidney Cancer Research BureauOTHER | 1 | Feb 6, 2014 | clinicaltrials |
| NCT01048892 | Seneca Valley Virus-001 and Cyclophosphamide in Treating Young Patients With Relapsed or Refractory Neuroblastoma, Rhabdomyosarcoma, or Rare Tumors With Neuroendocrine Features | completed | Phase 1 | 22 | Children's Oncology GroupNETWORK | 1 | Jan 30, 2014 | clinicaltrials |
| NCT00942058 | Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer(CA9CRM) | terminated | — | 16 | Centre Hospitalier Universitaire de Saint EtienneOTHER | 1 | Jan 29, 2014 | clinicaltrials |
| NCT01677390 | A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma | terminated | Phase 1 | 4 | Seagen Inc.INDUSTRY | 1 | Jan 28, 2014 | clinicaltrials |
| NCT00045487 | Erlotinib in Treating Patients With Advanced Kidney Cancer(OSI-774) | completed | Phase 2 | 41 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jan 27, 2014 | clinicaltrials |
| NCT00387764 | Extension Study to VEG105192 to Assess Pazopanib in Patients With Advanced/Metastatic Renal Cell Cancer | completed | Phase 3 | 80 | GlaxoSmithKlineINDUSTRY | 20 | Jan 14, 2014 | clinicaltrials |
| NCT00718367 | Correlation of the Clinical Behaviour of Renal Cell Carcinoma (RCC) After Debulking Nephrectomy With Tumor Gene Expression in Nephrectomy Specimens | completed | — | — | National University Hospital, SingaporeOTHER | 1 | Jan 14, 2014 | clinicaltrials |
| NCT00301990 | Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 65 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00717587 | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer | unknown | Phase 2 | 20 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Jan 10, 2014 | clinicaltrials |
| NCT00006864 | Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | completed | Phase 4 | — | Case Comprehensive Cancer CenterOTHER | 1 | Jan 9, 2014 | clinicaltrials |
| NCT00030888 | UCN-01 in Treating Patients With Advanced or Metastatic Kidney Cancer | unknown | Phase 2 | — | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00176501 | Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer | terminated | Phase 2 | 3 | Rutgers, The State University of New JerseyOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00295997 | Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia | unknown | N/A | 35 | University of California, San FranciscoOTHER | 1 | Jan 6, 2014 | clinicaltrials |
| NCT00836745 | Non-Interventional Study Of Indian Patients With Advanced Renal Cell Cancer Receiving Therapy With Sutent | completed | — | 36 | PfizerINDUSTRY | 1 | Dec 20, 2013 | clinicaltrials |
| NCT00002846 | Interleukin-2 in Treating Patients With Metastatic or Recurrent Kidney Cancer | unknown | Phase 2 | 14 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002847 | Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 14 | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00024063 | SU006668 in Treating Patients With Advanced Solid Tumors | unknown | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 0 | Dec 19, 2013 | clinicaltrials |
| NCT00053820 | Interferon Alfa With or Without Interleukin-2 and Fluorouracil in Treating Patients With Advanced Metastatic Kidney Cancer | completed | Phase 3 | 670 | Medical Research CouncilOTHER_GOV | 4 | Dec 19, 2013 | clinicaltrials |
| NCT00080977 | High-Dose Intravenous Interleukin-2 in Treating Patients With Metastatic Renal Cell Carcinoma (Kidney Cancer) That Has Not Responded to Previous Low-Dose Intravenous or Subcutaneous Interleukin-2 | unknown | Phase 2 | — | Blumenthal Cancer Center at Carolinas Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00093522 | Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer | unknown | Phase 2 | 28 | St. Luke's Medical CenterOTHER | 1 | Dec 19, 2013 | clinicaltrials |
| NCT00002589 | Lymphocyte Therapy in Treating Patients With Kidney Cancer | unknown | Phase 2 | 90 | National Cancer Institute (NCI)NIH | 1 | Dec 18, 2013 | clinicaltrials |
| NCT00586495 | Long-term Extension From RCC Phase II (11515) | completed | Phase 2 | 95 | BayerINDUSTRY | 1 | Dec 13, 2013 | clinicaltrials |
| NCT00003585 | Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer | completed | Phase 1 / Phase 2 | 35 | University of New MexicoOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00003181 | Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | 35 | Hope Cancer Institute, Inc.INDUSTRY | 1 | Dec 4, 2013 | clinicaltrials |
| NCT00602862 | Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250 | completed | N/A | 26 | Radboud University Medical CenterOTHER | 1 | Dec 2, 2013 | clinicaltrials |
| NCT00474786 | Temsirolimus Versus Sorafenib As Second-Line Therapy In Patients With Advanced RCC Who Have Failed First-Line Sunitinib(INTORSECT) | completed | Phase 3 | 512 | PfizerINDUSTRY | 20 | Nov 21, 2013 | clinicaltrials |
| NCT00876382 | Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma | completed | — | 47 | SCRI Development Innovations, LLCOTHER | 1 | Nov 14, 2013 | clinicaltrials |
| NCT01063998 | A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma | terminated | — | 23 | Jason HafronOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00003604 | Interleukin-2 in Treating Patients With Stage III or Stage IV Kidney Cancer That Has Been Removed With Surgery | unknown | Phase 2 | 20 | Cancer Biotherapy Research GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003664 | Combination Chemotherapy and Biological Therapy In Treating Patients With Kidney Cancer That Is Metastatic or Cannot Be Removed Surgically | unknown | Phase 2 | 30 | Cancer Biotherapy Research GroupOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00293501 | Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By Surgery | unknown | Phase 1 / Phase 2 | 35 | University of VermontOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00016237 | Interleukin-2 Combined With Monoclonal Antibody Therapy in Treating Patients With Kidney, Bladder, or Lung Cancer That Has Not Responded to Previous Treatment | completed | Phase 1 | — | EMD SeronoINDUSTRY | 1 | Oct 23, 2013 | clinicaltrials |
| NCT00110344 | Research Study for Patients With Metastatic Renal Cell Carcinoma | terminated | Phase 2 | 1 | BayerINDUSTRY | 1 | Oct 11, 2013 | clinicaltrials |
| NCT00289146 | Comparison of Immune Response Following Surgical Management of Renal Tumors | terminated | — | 50 | Emory UniversityOTHER | 1 | Sep 24, 2013 | clinicaltrials |
| NCT00005038 | Interleukin-2 With or Without Histamine Dihydrochloride in Treating Patients With Metastatic Kidney Cancer | unknown | Phase 2 | — | The Christie NHS Foundation TrustOTHER | 1 | Sep 20, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Apr 2, 2014source: clinicaltrials